UK markets closed

Shop Apotheke Europe N.V. (0RJT.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
97.03+0.81 (+0.84%)
At close: 05:17PM GMT
Full screen
Previous close96.22
Open95.28
BidN/A x N/A
AskN/A x N/A
Day's range93.32 - 96.32
52-week range93.32 - 96.32
Volume1,444
Avg. volumeN/A
Market capN/A
Beta (5Y monthly)0.69
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • EQS Group

    SHOP APOTHEKE EUROPE: STRONG ORGANIC GROWTH CONTINUES.

    EQS-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Preliminary Results/Development of SalesSHOP APOTHEKE EUROPE: STRONG ORGANIC GROWTH CONTINUES. 11.01.2023 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement.SHOP APOTHEKE EUROPE: STRONG ORGANIC GROWTH CONTINUES. Q4 total sales up by 14% year over year to EUR 328 million. Full year 2022 double-digit sales growth of 14% achieved; record EUR 1.2 billion total sales. Non-Rx sales growth 17% for the full year; 2022

  • EQS Group

    At the VISION 2045 Summit alongside the COP 27: CEO Stefan Feltens presents SHOP APOTHEKE EUROPE’s NET ZERO 2040 Strategy in Sharm El Sheikh.

    EQS-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): SustainabilityAt the VISION 2045 Summit alongside the COP 27: CEO Stefan Feltens presents SHOP APOTHEKE EUROPE’s NET ZERO 2040 Strategy in Sharm El Sheikh. 10.11.2022 / 09:00 CET/CESTThe issuer is solely responsible for the content of this announcement.At the VISION 2045 Summit alongside the COP 27:CEO Stefan Feltens presents SHOP APOTHEKE EUROPE’s NET ZERO 2040 Strategy in Sharm El Sheikh.Sevenum, November 10, 2022. From 07 to 09 November 2022,

  • EQS Group

    SHOP APOTHEKE EUROPE: SOLID AND SUCCESSFUL QUARTER, FULLY IN LINE WITH GUIDANCE. BETTER MARGINS AND CONTINUED MARKET SHARE GAINS.

    EQS-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Interim Report/9 Month figuresSHOP APOTHEKE EUROPE: SOLID AND SUCCESSFUL QUARTER, FULLY IN LINE WITH GUIDANCE. BETTER MARGINS AND CONTINUED MARKET SHARE GAINS. 31.10.2022 / 06:29 CET/CESTThe issuer is solely responsible for the content of this announcement.SHOP APOTHEKE EUROPE: SOLID AND SUCCESSFUL QUARTER, FULLY IN LINE WITH GUIDANCE. BETTER MARGINS AND CONTINUED MARKET SHARE GAINS. Group sales up 20% to EUR 285 million in Q3 (9M up 14% to EUR